Glaukos Future Growth
Future criteria checks 2/6
Glaukos is forecast to grow earnings and revenue by 69.5% and 20.7% per annum respectively. EPS is expected to grow by 71.7% per annum. Return on equity is forecast to be -5.4% in 3 years.
Key information
69.5%
Earnings growth rate
71.7%
EPS growth rate
Medical Equipment earnings growth | 12.9% |
Revenue growth rate | 20.7% |
Future return on equity | -5.4% |
Analyst coverage | Good |
Last updated | 28 Jan 2025 |
Recent future growth updates
Recent updates
Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Jan 17Are Investors Undervaluing Glaukos Corporation (NYSE:GKOS) By 50%?
Dec 25Glaukos: Still Bullish, But Embedded Expectations Are Now High
Dec 21Revenues Tell The Story For Glaukos Corporation (NYSE:GKOS)
Dec 03Is Glaukos (NYSE:GKOS) Using Debt In A Risky Way?
Sep 18Glaukos Corporation: Ripe For Some Consolidation
Sep 11Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 81% Above Its Share Price
Aug 28Glaukos Corporation (NYSE:GKOS) Just Reported And Analysts Have Been Lifting Their Price Targets
Aug 07Glaukos Corporation's (NYSE:GKOS) Popularity With Investors Is Clear
Jul 18Glaukos (NYSE:GKOS) Is Carrying A Fair Bit Of Debt
Jun 11Glaukos Stock: Still Unproven Whether A New Bull Market Has Begun
May 30Here's Why Glaukos Corporation's (NYSE:GKOS) CEO Compensation Is The Least Of Shareholders' Concerns
May 24Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching
Apr 22Glaukos Corporation (NYSE:GKOS) Not Lagging Industry On Growth Or Pricing
Apr 04Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 69% Above Its Share Price
Feb 21Glaukos: Remains A Hold Due To High Valuation And Negative Profitability
Jan 09Glaukos: Continued Growth Rates, Regulatory Tailwinds, And Support
Sep 01Glaukos: Revising To Buy On These 3 Catalytic Factors
Jun 16Glaukos: Trial Momentum Building, Profitability Differentials Yet To Pull Through
Feb 14Glaukos sees positive data from mid-stage trial of dry eye treatment
Jan 10Glaukos: Show Me The Money
Nov 10Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 745 | 4 | N/A | N/A | 2 |
12/31/2026 | 608 | -27 | 84 | 99 | 12 |
12/31/2025 | 479 | -69 | 2 | 29 | 14 |
12/31/2024 | 379 | -141 | -35 | -20 | 14 |
9/30/2024 | 360 | -150 | -81 | -72 | N/A |
6/30/2024 | 342 | -159 | -82 | -71 | N/A |
3/31/2024 | 326 | -141 | -75 | -61 | N/A |
12/31/2023 | 315 | -135 | -78 | -58 | N/A |
9/30/2023 | 304 | -129 | -75 | -51 | N/A |
6/30/2023 | 297 | -126 | -97 | -70 | N/A |
3/31/2023 | 289 | -139 | -104 | -74 | N/A |
12/31/2022 | 283 | -99 | -63 | -33 | N/A |
9/30/2022 | 285 | -90 | -65 | -34 | N/A |
6/30/2022 | 288 | -56 | -25 | 11 | N/A |
3/31/2022 | 294 | -28 | -7 | 30 | N/A |
12/31/2021 | 294 | -50 | -23 | 25 | N/A |
9/30/2021 | 294 | -38 | -1 | 40 | N/A |
6/30/2021 | 284 | -60 | -19 | 13 | N/A |
3/31/2021 | 238 | -83 | -29 | -6 | N/A |
12/31/2020 | 225 | -120 | -30 | -23 | N/A |
9/30/2020 | 218 | -73 | -44 | -38 | N/A |
6/30/2020 | 211 | -71 | -37 | -31 | N/A |
3/31/2020 | 238 | -37 | -19 | -14 | N/A |
12/31/2019 | 237 | 15 | -5 | 0 | N/A |
9/30/2019 | 225 | -19 | 10 | 21 | N/A |
6/30/2019 | 211 | -12 | 17 | 28 | N/A |
3/31/2019 | 195 | -12 | 16 | 26 | N/A |
12/31/2018 | 181 | -13 | 9 | 19 | N/A |
9/30/2018 | 169 | -14 | 10 | 14 | N/A |
6/30/2018 | 165 | -6 | N/A | 17 | N/A |
3/31/2018 | 163 | -4 | N/A | 17 | N/A |
12/31/2017 | 159 | 0 | N/A | 26 | N/A |
9/30/2017 | 151 | -1 | N/A | 17 | N/A |
6/30/2017 | 140 | -1 | N/A | 14 | N/A |
3/31/2017 | 127 | 5 | N/A | 16 | N/A |
12/31/2016 | 114 | 5 | N/A | 12 | N/A |
9/30/2016 | 102 | 2 | N/A | 8 | N/A |
6/30/2016 | 91 | -1 | N/A | 4 | N/A |
3/31/2016 | 80 | -35 | N/A | -2 | N/A |
12/31/2015 | 72 | -37 | N/A | -2 | N/A |
9/30/2015 | 66 | -40 | N/A | -3 | N/A |
6/30/2015 | 59 | -39 | N/A | -2 | N/A |
3/31/2015 | 52 | -9 | N/A | -3 | N/A |
12/31/2014 | 46 | -12 | N/A | -7 | N/A |
9/30/2014 | 38 | -11 | N/A | -8 | N/A |
6/30/2014 | 33 | -12 | N/A | -10 | N/A |
3/31/2014 | 26 | -13 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GKOS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GKOS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GKOS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: GKOS's revenue (20.7% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: GKOS's revenue (20.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GKOS is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/02 02:14 |
End of Day Share Price | 2025/01/31 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Glaukos Corporation is covered by 25 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ishan Majumdar | Baptista Research |
Ravi Misra | Berenberg |
Joanne Wuensch | BMO Capital Markets Equity Research |